Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Q-linea AB ( (SE:QLINEA) ).
Q-linea AB has announced an increase in its number of shares and votes following the exercise of TO1 warrants, resulting in a total of 6,430,039,725 shares. This expansion reflects the company’s growth and could enhance its market presence, impacting stakeholders by potentially increasing shareholder value.
More about Q-linea AB
Q-linea is a company specializing in rapid antimicrobial susceptibility testing (AST) systems, particularly the ASTar® system, which aids hospitals in quickly identifying optimal antimicrobial therapies for bloodstream infections and sepsis. The company is based in Uppsala, Sweden, with regional offices in Italy and the USA, and has a global partnership network. Their products are CE-IVD marked and FDA 510(k) cleared.
Average Trading Volume: 35,194,265
Current Market Cap: SEK200.6M
For detailed information about QLINEA stock, go to TipRanks’ Stock Analysis page.